ADVFN Logo ADVFN
Donnée du Marché
Actualité
Outils
Donnée du Marché
Discover

Hot Features

Follow Feed

Rester connecter avec les traders et investisseurs dans notre communauté Follow Feed.

Flux des Options

Explorez des données complètes sur les options et utilisez les filtres avancés avec Options Flow.

Moniteur

Organisez et surveillez vos d'actions et actifs avec le Moniteur.
Se connecter Premium IconPremium Help Menu
CAC 40
7 709,75
0,98%
Dow Jones
43 487,83
0,78%
DAX
20 903,39
1,31%
Brent Oil
80,005
0,00%
Bitcoin
103 433,53
-0,65%
Registration Strip Icon for monitor Surveillez plusieurs cotations en temps réel des principales bourses, telles que Euronext Paris, NASDAQ, NYSE, AMEX, Bovespa et plus encore.
S'inscrire
  1. Accueil
  2. Investir
  3. Actions
  4. Etats-Unis
  5. NASDAQ
  6. LENZ Therapeutics Inc (LENZ)

  7. LENZ Therapeutics Inc (LENZ) Actualités

LENZ

LENZ Therapeutics (LENZ)

LENZ Therapeutics Inc
De:
Trier par:
 Showing the most relevant articles for your search:NASDAQ:LENZ
DateHeureSourceTitreSymboleSociété
12/11/202414h00GlobeNewswire Inc.LENZ Therapeutics to Participate in Upcoming Investor ConferencesNASDAQ:LENZLENZ Therapeutics Inc
06/11/202413h00GlobeNewswire Inc.LENZ Therapeutics Reports Third Quarter 2024 Financial ResultsNASDAQ:LENZLENZ Therapeutics Inc
30/10/202413h00GlobeNewswire Inc.LENZ Therapeutics to Report Third Quarter Financial Results and Business Update on November 6, 2024NASDAQ:LENZLENZ Therapeutics Inc
28/10/202402h00GlobeNewswire Inc.CORXEL and LENZ Therapeutics Announce Positive Topline Data from China Phase 3 Presbyopia Trial of LNZ100NASDAQ:LENZLENZ Therapeutics Inc
21/10/202414h00GlobeNewswire Inc.LENZ Therapeutics Announces FDA Acceptance of New Drug Application for LNZ100 for the Treatment of PresbyopiaNASDAQ:LENZLENZ Therapeutics Inc
30/09/202414h00GlobeNewswire Inc.LENZ Therapeutics Announces Presentations at Upcoming Ophthalmology and Optometry Medical ConferencesNASDAQ:LENZLENZ Therapeutics Inc
14/08/202422h05GlobeNewswire Inc.LENZ Therapeutics Reports Second Quarter 2024 Financial ResultsNASDAQ:LENZLENZ Therapeutics Inc
12/08/202414h00GlobeNewswire Inc.LENZ Therapeutics Announces Submission of New Drug Application to U.S. Food and Drug Administration for LNZ100 for the Treatment of PresbyopiaNASDAQ:LENZLENZ Therapeutics Inc
07/08/202422h01GlobeNewswire Inc.LENZ Therapeutics to Report Second Quarter 2024 Financial Results on August 14, 2024NASDAQ:LENZLENZ Therapeutics Inc
15/07/202414h00GlobeNewswire Inc.LENZ Therapeutics Announces $30 Million Investment from Ridgeback CapitalNASDAQ:LENZLENZ Therapeutics Inc
10/06/202414h00GlobeNewswire Inc.LENZ Therapeutics to Host Key Opinion Leader Event on June 18, 2024NASDAQ:LENZLENZ Therapeutics Inc
30/05/202414h00GlobeNewswire Inc.LENZ Therapeutics to Present at the Jefferies Global Healthcare ConferenceNASDAQ:LENZLENZ Therapeutics Inc
21/05/202414h31Edgar (US Regulatory)Form S-8 - Securities to be offered to employees in employee benefit plansNASDAQ:LENZLENZ Therapeutics Inc
09/05/202422h18Edgar (US Regulatory)Form 424B3 - Prospectus [Rule 424(b)(3)]NASDAQ:LENZLENZ Therapeutics Inc
08/05/202423h11Edgar (US Regulatory)Form 10-Q - Quarterly report [Sections 13 or 15(d)]NASDAQ:LENZLENZ Therapeutics Inc
08/05/202422h05Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:LENZLENZ Therapeutics Inc
08/05/202422h01GlobeNewswire Inc.LENZ Therapeutics Reports First Quarter 2024 Financial Results and Provides Business UpdatesNASDAQ:LENZLENZ Therapeutics Inc
01/05/202422h01GlobeNewswire Inc.LENZ Therapeutics to Report First Quarter Financial Results and Business Update on May 8, 2024NASDAQ:LENZLENZ Therapeutics Inc
03/04/202413h00Business WireLENZ Therapeutics Announces Positive Topline Data from Phase 3 CLARITY Presbyopia TrialsNASDAQ:LENZLENZ Therapeutics Inc
02/04/202422h01Business WireLENZ Therapeutics to Host Investor Call to Discuss Topline Results from the Phase 3 CLARITY Presbyopia TrialsNASDAQ:LENZLENZ Therapeutics Inc
 Showing the most relevant articles for your search:NASDAQ:LENZ

Dernières Valeurs Consultées

EU
EN
Bouygues
NASDAQ
NVDA
NVIDIA
NASDAQ
AMZN
Amazon.com
EU
DG
Vinci
EU
CAP
Capgemini
COIN
BTCUSD
Bitcoin
NYSE
MCD
McDonalds
NASDAQ
AAPL
Apple
EU
PX4
SBF 120
COIN
DOGEUSD
Dogecoin
COIN
ADAUSD
Cardano
NYSE
MRK
Merck
EU
LR
Legrand
EU
MC
Lvmh Moet Hennessy Louis...
Delayed Upgrade Clock
ADVFN Logo
InvestorsHub

France
Société
Entreprise
Popular
Obtenir l'application
App Store
Google Play

Assistance: support@advfn.fr

En accédant aux services disponibles de ADVFN, vous acceptez les Conditions Générales de ADVFN Conditions Générales

© 2025 ADVFN PLC - Tous droits réservés